Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
PYFA.JK
Strong SellSinkerPT Pyridam Farma Tbk · Healthcare · Indonesia · $168M · Avg Vol: $378K/d
9
StockRankGet insider-trade alerts
Q
28
V
28
M
26
P/E (TTM)
—
ROE
-39.3%
D/E
6.0x
Dividend %
—
COMPANY DESCRIPTION
PT Pyridam Farma Tbk engages in the pharmaceutical business in Australia, Indonesia, Philippines, Singapore, and India. The company operates through two segments, Pharmaceutical Products, Esthetic and Toll Manufacturing Services; and Medical Equipment segments.
FINANCIAL SUMMARY (IDR)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 715.4B | 702.1B | 1.9T | 2.8T | 56.8% | 3.0T |
| EPS (IDR) | 24.49 | -7.58 | -38.91 | -33.79 | — | -29.54 |
| Shares | 11.2B | 11.2B | 11.2B | 11.2B | -0.0% | 11.2B |
| Debt | 910.0B | 987.0B | 3.9T | 4.8T | 74.6% | 5.4T |
| Equity | 442.1B | 356.8B | 1.0T | 767.0B | 20.2% | — |
| Op CF | 5.4B | -104.0B | -143.8B | -364.3B | — | -427.0B |
| Inv CF | -242.9B | -22.5B | -2.6T | -169.0B | — | — |
| Fin CF | 326.4B | 91.2B | 3.0T | 284.4B | — | — |
Loading 1Y...
PRICE (1Y)+29.7%
SMA 50SMA 200
Close
$0.015
RSI (14)
58.4
52W High
$0.04
From 52W High
0.4%
SCORE BREAKDOWN
Quality
28
ROIC
-2.7%41.8
ROE
-39.3%21.8
GP/Assets
9.7%25.0
Op. Margin
-0.2%33.0
FCF/Assets
n/mN/A
Piotroski
549.3
Int. Cover
-0.4x35.1
D/E Ratio
5.99x1.8
Current Ratio
0.85x7.2
Value
28
P/E (TTM)
—N/A
EV/EBITDA
103.2x4.6
P/FCF
n/mN/A
P/B
4.3x34.1
P/S
1.0x84.7
Div Yield
—N/A
Momentum
26
52W High %
37%11.1
RS 6M
-11%50.8
SMA 50/200
0.65x5.4
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$168M
P/E (Forward)
—
Gross Margin
21.9%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PYFA.JK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PYFA.JK | PT Pyridam Farma Tbk(you) | $168M | 9 | Strong Sell |
| KAEF.JK | PT Kimia Farma Tbk | $150M | 35 | Hold |
| LPKR.JK | PT Lippo Karawaci Tbk | $249M | 40 | Hold |
| SAME.JK | PT Sarana Meditama Metropolitan Tbk | $308M | 46 | Hold |
| HEAL.JK | PT Medikaloka Hermina Tbk | $589M | 35 | Sell |
| SRAJ.JK | PT Sejahteraraya Anugrahjaya Tbk | $9.2B | 13 | Strong Sell |
| SOHO.JK | PT Soho Global Health Tbk | $1.2B | 57 | Hold |
| PRDA.JK | PT Prodia Widyahusada Tbk | $142M | 100 | Strong Buy |
| MARK.JK | PT Mark Dynamics Indonesia Tbk | $233M | 100 | Strong Buy |
| SILO.JK | PT Siloam International Hospitals Tbk | $1.6B | 78 | Buy |
Peer medians: ROE 9.2% · P/E 18.6x · Gross margin 37.3%